Dermapharm Holding SE
XETRA:DMP
Dermapharm Holding SE
XETRA:DMP
Price:
33.5 EUR
4.36%
Market Closed
Updated:
May 4, 2024
Dermapharm Holding SE
Cash from Operating Activities
|
Dermapharm Holding SE
Cash from Operating Activities Peer Comparison
Comparables:
ATAI
BAYN
MRK
93M1
PSG
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Dermapharm Holding SE
XETRA:DMP
|
Cash from Operating Activities
€218.6m
|
CAGR 3-Years
18%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Cash from Operating Activities
-$84.1m
|
CAGR 3-Years
-59%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bayer AG
XETRA:BAYN
|
Cash from Operating Activities
€5.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
0%
|
|
|
Merck KGaA
XETRA:MRK
|
Cash from Operating Activities
€3.8B
|
CAGR 3-Years
3%
|
CAGR 5-Years
11%
|
CAGR 10-Years
5%
|
|
|
MPH Health Care AG
XETRA:93M1
|
Cash from Operating Activities
€12m
|
CAGR 3-Years
56%
|
CAGR 5-Years
64%
|
CAGR 10-Years
N/A
|
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Cash from Operating Activities
€24.7m
|
CAGR 3-Years
12%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
See Also
What is Dermapharm Holding SE's Cash from Operating Activities?
Cash from Operating Activities
218.6m
EUR
218.6m
EUR
Based on the financial report for Dec 31, 2023, Dermapharm Holding SE's Cash from Operating Activities amounts to 218.6m EUR.
What is Dermapharm Holding SE's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
7%
7%
Over the last year, the Cash from Operating Activities growth was -24%. The average annual Cash from Operating Activities growth rates for Dermapharm Holding SE have been 18% over the past three years , 7% over the past five years .
You don't have any saved screeners yet
